ACGN - Aceragen Inc
IEX Last Trade
0.427
-0.063 -14.754%
Share volume: 128,513
Last Updated: Tue 08 Aug 2023 07:10:37 PM CEST
Biological Product (except Diagnostic) Manufacturing :
-3.41%
PREVIOUS CLOSE
CHG
CHG%
$0.49
-0.06
-12.86%
Fundamental analysis
76%
Profitability
93%
Dept financing
25%
Liquidity
0%
Performance
90%
Performance
5 Days
-39.07%
1 Month
-69.75%
3 Months
-79.63%
6 Months
-91.82%
1 Year
-92.80%
2 Year
-97.28%
Key data
Stock price
$0.43
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.47 - $16.00
52 WEEK CHANGE
-$0.93
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Vincent Milano
Region: US
Website: http://www.iderapharma.com/
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Biological Product (except Diagnostic) Manufacturing
Sector: Manufacturing
Region: US
Website: http://www.iderapharma.com/
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Biological Product (except Diagnostic) Manufacturing
Sector: Manufacturing
idera pharmaceuticals is a clinical stage biotechnology company with expertise in discovering, developing and commercializing novel nucleic acid therapeutics to treat patients with serious and life-threatening diseases. idera is focused on harnessing the potential of our proprietary technology to treat genetically defined forms of b-cell lymphomas and rare autoimmune diseases.
Recent news